Qube Research & Technologies (QRT)’s Mirum Pharmaceuticals MIRM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-109,001	Closed	-$8.61M	–	3895
2025 Q4	$8.61M	Buy	109,001 +63,949	+142%	+$4.59M	0.01%	1443
2025 Q3	$3.3M	Sell	45,052 -113,976	-72%	-$7.25M	﹤0.01%	1987
2025 Q2	$8.09M	Buy	159,028 +19,594	+14%	+$872K	0.01%	1420
2025 Q1	$6.28M	Buy	+139,434	New	+$6.57M	0.01%	1418
2024 Q2	–	Sell	-241,498	Closed	-$6.07M	–	4391
2024 Q1	$6.07M	Buy	241,498 +116,857	+94%	+$3.21M	0.01%	1122
2023 Q4	$3.68M	Buy	+124,641	New	+$3.77M	0.01%	1197
2023 Q3	–	Sell	-39,891	Closed	-$1.03M	–	4245
2023 Q2	$1.03M	Buy	+39,891	New	+$1.06M	﹤0.01%	1283

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MIRM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 109,001 shares — an estimated $8.61M sold.

Qube Research & Technologies (QRT) first reported a position in MIRM in Q2 2023 and held it in 7 quarters. The position peaked at $8.61M in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 109,001 Mirum Pharmaceuticals shares in Q1 2026, an estimated $8.61M.
Qube Research & Technologies (QRT) first reported a position in Mirum Pharmaceuticals in Q2 2023 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Mirum Pharmaceuticals position peaked at $8.61M in Q4 2025.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.